| Product NDC: | 0088-1203 |
| Proprietary Name: | Anzemet |
| Non Proprietary Name: | dolasetron mesylate |
| Active Ingredient(s): | 100 mg/1 & nbsp; dolasetron mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0088-1203 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020623 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970911 |
| Package NDC: | 0088-1203-43 |
| Package Description: | 10 TABLET, FILM COATED in 1 DOSE PACK (0088-1203-43) |
| NDC Code | 0088-1203-43 |
| Proprietary Name | Anzemet |
| Package Description | 10 TABLET, FILM COATED in 1 DOSE PACK (0088-1203-43) |
| Product NDC | 0088-1203 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dolasetron mesylate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19970911 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | DOLASETRON MESYLATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |